ModivCare Inc: Nasdaq/NYSE listing notice — ModivCare reports Q1 net loss of $50.4M; receives Nasdaq delisting notice for low MVPHS

ModivCare Inc

Service revenue $650.7M, down 4.9% YoY; adjusted EBITDA $32.6M (5.0% of revenue).
Net loss $50.4M (-$3.52 EPS); adjusted net loss $24.5M (-$1.71 EPS).
NEMT revenue $449.0M (-6.3% YoY), Adj. EBITDA margin 6.2%; PCS Adj. EBITDA up 8.5% YoY.
Nasdaq notice: MVPHS below $15M for 30 days; 180-day compliance period ends Nov 1, 2025.
Executed $105M in new financing; targeting >$20M annualized G&A savings.

item 2.02 item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

ModivCare Inc received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(C), 5810(c)(3)(D)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(3)(C), 5810(c)(3)(D)

Exact text from the filing

r applicable Nasdaq rule excludes shares held by beneficial owners of more than 10% of our total shares outstanding and shares held by our officers and directors, closed below the $15,000,000 MVPHS threshold required for continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(b)(3)(C). The Notice has no immediate effect on the listing of the Company’s common stock on The Nasdaq Global Select Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(D), the Company has a compliance period of 180 calendar days, or until November 1, 2025, to regain compliance with the MVPHS r

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001220754-25-000034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.